GOCOVRI 137 mg/1

GOCOVRI 137 mg/1 is a coated pellet capsule containing amantadine, used for managing certain movement disorders. This medication is designed for oral administration and is manufactured by Supernus Pharmaceuticals in the USA.

GOCOVRI 137 mg/1 is primarily used to help manage symptoms associated with movement disorders. Amantadine, the active ingredient, is often prescribed to address specific motor function issues. Patients may wonder, 'What is GOCOVRI used for?' This medication is typically utilized as part of a broader treatment plan for conditions affecting movement and coordination.

Common effects of GOCOVRI 137 mg/1 may include changes in motor function and potential side effects such as dizziness or nausea. Individual responses can vary, and it's important to monitor how the body reacts to the medication. Always consult a healthcare provider for personalized advice.

When handling GOCOVRI 137 mg/1, it's important to follow the prescribed dosage and administration instructions. Store the medication in a cool, dry place away from direct sunlight. Avoid sudden changes in dosage without consulting a healthcare professional.

GOCOVRI 137 mg/1 may interact with certain medications, including those that affect the central nervous system. Alcohol and other depressants should be avoided unless approved by a healthcare provider. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.